CYC116 (CYC-116)is an oral small molecule Aurora kinase/VEGFR2 inhibitor with antineoplastic activity. It inhibits Aurora kinases A and B and VEGFR2, resulting in disruption of the cell cycle, rapid cell death, and the inhibition of angiogenesis. [1]